About Syneron Medical (NASDAQ:ELOS)
Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.
Industry, Sector and Symbol
Industry Medical Equipment, Supplies & Distribution
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-1.74%
Return on Assets-1.30%
Syneron Medical (NASDAQ:ELOS) Frequently Asked Questions
What is Syneron Medical's stock symbol?
Syneron Medical trades on the NASDAQ under the ticker symbol "ELOS."
How were Syneron Medical's earnings last quarter?
Syneron Medical Ltd. (NASDAQ:ELOS) released its quarterly earnings results on Thursday, August, 4th. The medical equipment provider reported $0.09 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.06 by $0.03. The medical equipment provider earned $75 million during the quarter, compared to analysts' expectations of $75.72 million. Syneron Medical had a negative net margin of 1.09% and a negative return on equity of 1.74%. The business's quarterly revenue was up 2.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.07 earnings per share. View Syneron Medical's Earnings History.
Where is Syneron Medical's stock going? Where will Syneron Medical's stock price be in 2017?
1 Wall Street analysts have issued 12-month price objectives for Syneron Medical's shares. Their forecasts range from $11.00 to $11.00. On average, they expect Syneron Medical's stock price to reach $11.00 in the next twelve months. View Analyst Ratings for Syneron Medical.
Who are some of Syneron Medical's key competitors?
Some companies that are related to Syneron Medical include K2M Group (KTWO), Exactech (EXAC), Invacare (IVC), STAAR Surgical (STAA), Landauer (LDR), Cryolife (CRY), AtriCure (ATRC), Meridian Bioscience (VIVO), Consort Medical (CSRT), Transenterix (TRXC), SurModics (SRDX), Utah Medical Products (UTMD), Antares Pharma (ATRS), Sientra (SIEN), CRH Medical (CRHM), T2 Biosystems (TTOO), Ocular Therapeutix (OCUL) and SeaSpine (SPNE).
Who are Syneron Medical's key executives?
Syneron Medical's management team includes the folowing people:
- Shimon Eckhouse Ph.D., Chairman of the Board
- Amit Meridor, Chief Executive Officer
- , Bio & Compensation -
- Hugo Goldman, Chief Financial Officer
- , Bio & Compensation -
- Erik Dowell, Vice President-North America
- William Griffing, Chief Executive Officer - Syneron Candela North America
- Shlomo Alkalay, Chief Operating Officer
- Lisa A. Soderquist, Chief Human Resource Officer
- , Bio & Compensation -
- Robert Ruck, Executive Vice President, Asia Pacific
- Robert Fielitz, Vice President and Managing Director of Europe, Middle East and Africa
- Sarit Soccary Ben-Yochanan, Vice President - Business Development & Strategy
Who owns Syneron Medical stock?
Who sold Syneron Medical stock? Who is selling Syneron Medical stock?
How do I buy Syneron Medical stock?
Shares of Syneron Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Syneron Medical's stock price today?
One share of Syneron Medical stock can currently be purchased for approximately $11.00.
How big of a company is Syneron Medical?
Syneron Medical has a market capitalization of $387.56 million. Syneron Medical employs 817 workers across the globe.
How can I contact Syneron Medical?
Syneron Medical's mailing address is Tavor Building 4 P.O. Box 550, YOKNEAM, 2069200, Israel. The medical equipment provider can be reached via phone at +972-7-32442200.
MarketBeat Community Rating for Syneron Medical (ELOS)MarketBeat's community ratings are surveys of what our community members think about Syneron Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Syneron Medical (NASDAQ:ELOS) Earnings History and Estimates Chart
Syneron Medical (NASDAQ ELOS) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/15/2017||Q416||$0.03||($0.03)||$82.02 million||$82.90 million||View||Listen|
|11/9/2016||Q316||($0.02)||$0.02||$68.08 million||$71.50 million||View||Listen|
|8/4/2016||Q216||$0.06||$0.09||$75.72 million||$75.00 million||View||Listen|
|5/19/2016||Q116||$0.01||$0.04||$64.38 million||$68.70 million||View||Listen|
|2/22/2016||Q415||$0.07||$0.07||$75.56 million||$78.90 million||View||Listen|
|11/11/2015||Q315||$0.03||$0.03||$66.60 million||$62.10 million||View||Listen|
|8/4/2015||Q215||$0.06||$0.04||$70.93 million||$73.50 million||View||N/A|
|5/13/2015||Q115||$0.01||$0.02||$62.08 million||$63.40 million||View||Listen|
|2/18/2015||Q414||$0.06||$0.09||$71.42 million||$74.10 million||View||N/A|
|11/12/2014||Q314||$0.03||$0.03||$58.32 million||$60.30 million||View||N/A|
|8/6/2014||Q214||$0.07||$0.07||$63.52 million||$64.60 million||View||Listen|
|5/14/2014||Q114||$0.04||$0.04||$55.50 million||$56.80 million||View||N/A|
|2/20/2014||Q413||$0.08||$0.11||$65.70 million||$64.30 million||View||Listen|
|11/13/2013||Q313||$0.01||$0.04||$62.06 million||$62.70 million||View||Listen|
|8/14/2013||Q2 2013||$0.09||$0.02||$70.93 million||$68.80 million||View||N/A|
|5/22/2013||Q1 2013||$0.02||$0.02||$61.19 million||$61.20 million||View||N/A|
|2/12/2013||Q4 2012||$0.09||$0.11||$70.60 million||$72.80 million||View||N/A|
|11/7/2012||Q312||$0.04||$0.03||$65.51 million||$60.13 million||View||N/A|
Syneron Medical (NASDAQ:ELOS) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Syneron Medical (NASDAQ:ELOS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Syneron Medical (NASDAQ ELOS)
No insider trades for this company have been tracked by MarketBeat.com
Syneron Medical (NASDAQ ELOS) News Headlines
Syneron Medical (NASDAQ:ELOS) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Syneron Medical (NASDAQ:ELOS) Income Statement, Balance Sheet and Cash Flow Statement
Syneron Medical (NASDAQ ELOS) Stock Chart for Thursday, December, 14, 2017